LAURA ASHLEY SMITH
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family HURLBURT FIELD, FL NPI 1629422282
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family FL NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$4,348.63
- Category: General Payments
- Program years: PY2021–2024
- Record count: 235
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,116.17 across 58 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,116.17 | 58 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $170.70 | 9 |
| Celgene Corporation | $110.87 | 4 |
| Merck Sharp & Dohme Corporation | $87.34 | 4 |
| Coherus Biosciences Inc. | $59.92 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $58.06 | 2 |
| Daiichi Sankyo Inc. | $53.35 | 3 |
| E.R. Squibb & Sons, L.L.C. | $50.89 | 3 |
| Janssen Biotech, Inc. | $46.79 | 3 |
| PharmaEssentia USA Corporation | $42.15 | 2 |
| PFIZER INC. | $39.08 | 2 |
| GENZYME CORPORATION | $36.68 | 2 |
| Exelixis Inc. | $34.60 | 2 |
| Ipsen Biopharmaceuticals, Inc | $33.11 | 2 |
| Lilly USA, LLC | $31.67 | 2 |
| Genentech USA, Inc. | $30.85 | 2 |
| ARRAY BIOPHARMA INC | $28.99 | 2 |
| Deciphera Pharmaceuticals Inc. | $24.67 | 1 |
| ABBVIE INC. | $22.16 | 1 |
| Acerta Pharma LLC | $21.29 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $18.88 | 1 |
| EISAI INC. | $18.73 | 1 |
| CSL Behring | $17.31 | 1 |
| Karyopharm Therapeutics Inc. | $17.09 | 1 |
| GlaxoSmithKline, LLC. | $16.68 | 1 |
| Sumitomo Pharma America, Inc. | $15.04 | 1 |
| Regeneron Healthcare Solutions, Inc. | $14.99 | 1 |
| Acrotech Biopharma Inc. | $14.28 | 1 |
By program year
Records — PY2024 (58)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.